| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.5 | 0.003 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |